Review Article
Objective: In pharmaceutics, Novel Drug Delivery Systems (NDDS) have become cutting edge methods for enhancing the therapeutic efficacy, bioavailability, stability, and safety of medications while lowering dosage frequency and systemic side effects. Poor solubility, limited bioavailability, quick drug elimination, and nonspecific drug distribution can all be linked to conventional drug administration methods. By delivering medications in a regulated, sustained, or targeted manner and keeping drug concentrations within the therapeutic range, NDDS are intended to get around these restrictions.
Major drug-delivery technologies: The main innovative drug delivery strategies, such as transdermal, sustained-release, controlled-release, targeted, and carrier-based drug delivery systems, are summarized in this review. The mechanisms and potential benefits of a variety of carrier systems, including liposomes, phytosomes, nanoparticles, microspheres, niosomes, transferosomes, ethosomes, dendrimers, monoclonal antibodies, emulsions, and hydrogels, are covered. Important drug-release mechanisms, such as diffusion, dissolution, erosion, swelling, osmotic, ion-exchange, pH-responsive, ligand-mediated, and stimuli responsive mechanisms, are also included in the review.
Key Findings: Additionally covered are evaluation characteristics such stability studies, in vitro drug release, zeta potential, particle size, and drug entrapment efficiency. Applications of NDDS in cancer, transdermal therapy, pulmonary and neurodegenerative diseases, cardiovascular disorders, and diabetes management are highlighted. Recent developments in advanced biomaterials and nanotechnology show promise for improving drug targeting, therapeutic results, and patient compliance.
Future Perspectives: In contemporary pharmaceutical practice, NDDS offer potential approaches for effective and efficient drug administration with fewer side effects, enhanced therapeutic performance, and better overall clinical results.
Loading publication timeline...